{
  "paper_id": "PMC11677710",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11677710/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Figure 1.",
      "caption": "The pathway of drugs targeting HER2 for the treatment of HER2+ breast cancer.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/f2a9b342402e/ijms-25-13376-g001.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/f2a9b342402e/ijms-25-13376-g001.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/f2a9b342402e/ijms-25-13376-g001.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/f2a9b342402e/ijms-25-13376-g001.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "ijms-25-13376-f001",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/f2a9b342402e/ijms-25-13376-g001.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11677710/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/f2a9b342402e/ijms-25-13376-g001.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Figure 2.",
      "caption": "Function of the PI3K/AKT pathway and its involvement in anti-HER2 treatment resistance. HER2, human epidermal growth factor receptor 2; PI3K, phosphoinositide 3-kinase; HER2-HET, HER2-heterogeneous; DPAGT1, dolichyl-phosphate N-acetylglucosaminephosphotransferase 1; ECD, extracellular domain; PIP2, phosphatidylinositol-4,5-bisphosphate; PIP3, phosphatidylinositol-3,4,5-trisphosphate; PTEN, phosphatase and tension homolog; mTORC, mammalian target of rapamycin complex; TSC, tuberous sclerosis complex; 4EBP1, eukaryotic translation initiation factor 4E-binding protein 1; S6K, ribosomal protein S6 kinase; FOXO, forkhead box O; FOXM1, forkhead box protein M1; ALDH, aldehyde dehydrogenase; IL-8, interleukin-8; CSC, cancer stem cell; GSK-3β, glycogen synthase kinase 3 beta; GPCPD1, glycerophosphodiesterase 1; TSPAN8, tetraspanin-8; STAT3, signal transducer and activator of transcription 3; IKK, inhibitor of kappa B kinase; MDM2, murine double minute 2; BAD, BCL2-associated agonist of cell death; Bcl-2, B-cell lymphoma 2; BCL-XL, B-cell lymphoma-extra-large; MYC, myelocytomatosis oncogene; MMP9, matrix metalloproteinase-9.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/b197ddb98c21/ijms-25-13376-g002.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/b197ddb98c21/ijms-25-13376-g002.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/b197ddb98c21/ijms-25-13376-g002.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/b197ddb98c21/ijms-25-13376-g002.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "ijms-25-13376-f002",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/b197ddb98c21/ijms-25-13376-g002.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11677710/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/b197ddb98c21/ijms-25-13376-g002.jpg"
    },
    "figure_3": {
      "figure_number": "Figure 3",
      "title": "Figure 3.",
      "caption": "The role of the PI3K/AKT pathway in the resistance to anti-HER2 therapy with crosstalk of other signaling pathways. HER2, human epidermal growth factor receptor 2; PI3K, phosphoinositide 3-kinase; PIP2, phosphatidylinositol-4,5-bisphosphate; PIP3, phosphatidylinositol-3,4,5-trisphosphate; PTEN, phosphatase and tension homolog; mTORC, mammalian target of rapamycin complex; CDK4/6, Cyclin-dependent kinases 4 and 6; ER, estrogen receptor; 14,15-EET, 14,15-Epoxyeicosatrienoic acid; GRB7, growth factor receptor-bound protein 7; FAK, focal adhesion kinase; Rb, retinoblastoma protein; AXL, AXL receptor tyrosine kinase; EMT, epithelial–mesenchymal transition; GAS6, growth arrest-specific 6; IGF-1R, insulin-like growth factor 1 receptor; IRS1, insulin receptor substrate; HER3, human epidermal growth factor receptor 3; STAT6, signal transducer and activator of transcription 6; HDAC, histone deacetylase; PPP3CB, protein phosphatase 3 catalytic subunit beta; FOXO, forkhead box O; TGFβ, transforming growth factor-beta; SMAD3, mothers against decapentaplegic homolog 3; PCBP1, Poly (C)-binding protein 1; SCF, Skp, Cullin, F-box-containing complex; Skp2, S-phase kinase-associated protein 2.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/d1c7d21fa7a6/ijms-25-13376-g003.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/d1c7d21fa7a6/ijms-25-13376-g003.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/d1c7d21fa7a6/ijms-25-13376-g003.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/d1c7d21fa7a6/ijms-25-13376-g003.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "ijms-25-13376-f003",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/d1c7d21fa7a6/ijms-25-13376-g003.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11677710/images/figure_3.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d7d/11677710/d1c7d21fa7a6/ijms-25-13376-g003.jpg"
    }
  },
  "claims": [
    {
      "sentence": "These measures inhibit HER2 signaling and exert antitumor effects (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In HER2+ BC cells, the activation or alteration of these pathways plays a vital role in various cellular processes, including proliferation, apoptosis, and glucose metabolism (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The upregulation of RTKs such as HER3, HGF/c-MET, AXL, and FGFR enhances the PI3K/AKT/mTOR anx Src pathways, promoting tumor cell proliferation (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These measures inhibit HER2 signaling and exert antitumor effects (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In HER2+ BC cells, the activation or alteration of these pathways plays a vital role in various cellular processes, including proliferation, apoptosis, and glucose metabolism (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The upregulation of RTKs such as HER3, HGF/c-MET, AXL, and FGFR enhances the PI3K/AKT/mTOR anx Src pathways, promoting tumor cell proliferation (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These measures inhibit HER2 signaling and exert antitumor effects (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In HER2+ BC cells, the activation or alteration of these pathways plays a vital role in various cellular processes, including proliferation, apoptosis, and glucose metabolism (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The upregulation of RTKs such as HER3, HGF/c-MET, AXL, and FGFR enhances the PI3K/AKT/mTOR anx Src pathways, promoting tumor cell proliferation (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These measures inhibit HER2 signaling and exert antitumor effects (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In HER2+ BC cells, the activation or alteration of these pathways plays a vital role in various cellular processes, including proliferation, apoptosis, and glucose metabolism (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The upregulation of RTKs such as HER3, HGF/c-MET, AXL, and FGFR enhances the PI3K/AKT/mTOR anx Src pathways, promoting tumor cell proliferation (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These measures inhibit HER2 signaling and exert antitumor effects (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In HER2+ BC cells, the activation or alteration of these pathways plays a vital role in various cellular processes, including proliferation, apoptosis, and glucose metabolism (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The upregulation of RTKs such as HER3, HGF/c-MET, AXL, and FGFR enhances the PI3K/AKT/mTOR anx Src pathways, promoting tumor cell proliferation (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These measures inhibit HER2 signaling and exert antitumor effects (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In HER2+ BC cells, the activation or alteration of these pathways plays a vital role in various cellular processes, including proliferation, apoptosis, and glucose metabolism (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The upregulation of RTKs such as HER3, HGF/c-MET, AXL, and FGFR enhances the PI3K/AKT/mTOR anx Src pathways, promoting tumor cell proliferation (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These measures inhibit HER2 signaling and exert antitumor effects (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In HER2+ BC cells, the activation or alteration of these pathways plays a vital role in various cellular processes, including proliferation, apoptosis, and glucose metabolism (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The upregulation of RTKs such as HER3, HGF/c-MET, AXL, and FGFR enhances the PI3K/AKT/mTOR anx Src pathways, promoting tumor cell proliferation (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These measures inhibit HER2 signaling and exert antitumor effects (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In HER2+ BC cells, the activation or alteration of these pathways plays a vital role in various cellular processes, including proliferation, apoptosis, and glucose metabolism (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The upregulation of RTKs such as HER3, HGF/c-MET, AXL, and FGFR enhances the PI3K/AKT/mTOR anx Src pathways, promoting tumor cell proliferation (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "These measures inhibit HER2 signaling and exert antitumor effects (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "These measures inhibit HER2 signaling and exert antitumor effects (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In HER2+ BC cells, the activation or alteration of these pathways plays a vital role in various cellular processes, including proliferation, apoptosis, and glucose metabolism (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The upregulation of RTKs such as HER3, HGF/c-MET, AXL, and FGFR enhances the PI3K/AKT/mTOR anx Src pathways, promoting tumor cell proliferation (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "In HER2+ BC cells, the activation or alteration of these pathways plays a vital role in various cellular processes, including proliferation, apoptosis, and glucose metabolism (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "In HER2+ BC cells, the activation or alteration of these pathways plays a vital role in various cellular processes, including proliferation, apoptosis, and glucose metabolism (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The upregulation of RTKs such as HER3, HGF/c-MET, AXL, and FGFR enhances the PI3K/AKT/mTOR anx Src pathways, promoting tumor cell proliferation (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "The upregulation of RTKs such as HER3, HGF/c-MET, AXL, and FGFR enhances the PI3K/AKT/mTOR anx Src pathways, promoting tumor cell proliferation (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 3,
    "claims_count": 32,
    "images_downloaded": 3,
    "tables_filtered": 32
  }
}